Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

被引:240
作者
Rehermann, B
Chang, KM
McHutchison, J
Kokka, F
Houghton, M
Rice, CM
Chisari, FV
机构
[1] Scripps Res Inst, DEPT MOL & EXPT MED, LA JOLLA, CA 92037 USA
[2] SCRIPPS CLIN, DIV GASTROENTEROL, MED GRP, LA JOLLA, CA 92037 USA
[3] CHIRON CORP, EMERYVILLE, CA 94608 USA
[4] WASHINGTON UNIV, SCH MED, DEPT MOL MICROBIOL, ST LOUIS, MO 63110 USA
关键词
D O I
10.1128/JVI.70.10.7092-7102.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cytotoxic T lymphocytes (CTL) are thought to control hepatitis B virus (HBV) infection, since they are readily detectable in patients who clear the virus whereas they are hard to detect during chronic HBV infection. In chronic hepatitis C virus (HCV) infection, however, the virus persists in the face of a CTL response. Indeed, most infected patients respond to one or more HCV-1 (genotype 1a)-derived CTL epitopes in the core, NS3, and NS4 proteins, and the CTL response is equally strong in patients infected by infected by different HCV genotypes, suggesting broad cross-reactivity. To examine the effect of the HCV-specific CTL response in patients with chronic hepatitits C on viral load and disease activity, we quantitated the strength of the multispecific CTL response against 10 independent epitopes within the HCV polyprotein. We could not detect a linear correlation between the CTL response and viral load or disease activity in these patients. However, the CTL response was stronger in the subgroup of patients whose HCV RNA was below the detection threshold of the HCV branched-chain DNA assay than in branched-chain-DNA-positive patients. These results suggest that the HCV-specific CTL response may be able to control viral load to some extent in chronically infected patients, and they indicate that prospective studies in acutely infected patients who successfully clear HCV should be performed to more precisely define the relationship between CTL responsiveness, viral clearance, and disease severity in this infection.
引用
收藏
页码:7092 / 7102
页数:11
相关论文
共 25 条
  • [1] THE NATURAL-HISTORY OF COMMUNITY-ACQUIRED HEPATITIS-C IN THE UNITED-STATES
    ALTER, MJ
    MARGOLIS, HS
    KRAWCZYNSKI, K
    JUDSON, FN
    MARES, A
    ALEXANDER, WJ
    HU, PY
    MILLER, JK
    GERBER, MA
    SAMPLINER, RE
    MEEKS, EL
    BEACH, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) : 1899 - 1905
  • [2] SPORADIC NON-A, NON-B HEPATITIS - FREQUENCY AND EPIDEMIOLOGY IN AN URBAN UNITED-STATES POPULATION
    ALTER, MJ
    GERETY, RJ
    SMALLWOOD, LA
    SAMPLINER, RE
    TABOR, E
    DEINHARDT, F
    FROSNER, G
    MATANOSKI, GM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1982, 145 (06) : 886 - 893
  • [3] RISK-FACTORS FOR ACUTE NON-A, NON-B HEPATITIS IN THE UNITED-STATES AND ASSOCIATION WITH HEPATITIS-C VIRUS-INFECTION
    ALTER, MJ
    HADLER, SC
    JUDSON, FN
    MARES, A
    ALEXANDER, WJ
    HU, PY
    MILLER, JK
    MOYER, LA
    FIELDS, HA
    BRADLEY, DW
    MARGOLIS, HS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (17): : 2231 - 2235
  • [4] PATIENTS WITH CHRONIC HEPATITIS-C HAVE CIRCULATING CYTOTOXIC T-CELLS WHICH RECOGNIZE HEPATITIS-C VIRUS-ENCODED PEPTIDES BINDING TO HLA-A2.1 MOLECULES
    BATTEGAY, M
    FIKES, J
    DIBISCEGLIE, AM
    WENTWORTH, PA
    SETTE, A
    CELIS, E
    CHING, WM
    GRAKOUL, A
    RICE, CM
    KUROKOHCHI, K
    BERZOFSKY, JA
    HOOFNAGLE, JH
    FEINSTONE, SM
    AKATSUKA, T
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (04) : 2462 - 2470
  • [5] HLA CLASS-I-RESTRICTED HUMAN CYTOTOXIC T-CELLS RECOGNIZE ENDOGENOUSLY SYNTHESIZED HEPATITIS-B VIRUS NUCLEOCAPSID ANTIGEN
    BERTOLETTI, A
    FERRARI, C
    FIACCADORI, F
    PENNA, A
    MARGOLSKEE, R
    SCHLICHT, HJ
    FOWLER, P
    GUILHOT, S
    CHISARI, FV
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) : 10445 - 10449
  • [6] HUMAN CYTOMEGALOVIRUS-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T - REQUIREMENTS FOR INVITRO GENERATION AND SPECIFICITY
    BORYSIEWICZ, LK
    MORRIS, S
    PAGE, JD
    SISSONS, JGP
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1983, 13 (10) : 804 - 809
  • [7] QUANTITATIVE-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOTOXIC LYMPHOCYTE-T (CTL) RESPONSE AT DIFFERENT STAGES OF HIV-1 INFECTION - DIFFERENTIAL CTL RESPONSES TO HIV-1 AND EPSTEIN-BARR-VIRUS IN LATE DISEASE
    CARMICHAEL, A
    JIN, X
    SISSONS, P
    BORYSIEWICZ, L
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) : 249 - 256
  • [8] CYTOTOXIC T-LYMPHOCYTE RESPONSE TO HEPATITIS-C VIRUS-DERIVED PEPTIDES CONTAINING THE HLA A2.1 BINDING MOTIF
    CERNY, A
    MCHUTCHISON, JG
    PASQUINELLI, C
    BROWN, ME
    BROTHERS, MA
    GRABSCHEID, B
    FOWLER, P
    HOUGHTON, M
    CHISARI, FV
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) : 521 - 530
  • [9] ANALYSIS OF A NEW HEPATITIS-C VIRUS TYPE AND ITS PHYLOGENETIC RELATIONSHIP TO EXISTING VARIANTS
    CHAN, SW
    MCOMISH, F
    HOLMES, EC
    DOW, B
    PEUTHERER, JF
    FOLLETT, E
    YAP, PL
    SIMMONDS, P
    [J]. JOURNAL OF GENERAL VIROLOGY, 1992, 73 : 1131 - 1141
  • [10] CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333